Cargando…
Delayed esophageal anastomotic complication and ramucirumab therapy: A case report
Current NCCN guidelines for second‐line therapy in recurrent or metastatic esophago‐gastric cancers recommend the use of VEGF inhibitors such as ramucirumab. VEGF inhibitors have been shown to be associated with gastrointestinal perforation in clinical trials and late colorectal anastomotic leaks in...
Autores principales: | Roth, Robert H., Malfitano, Madison J., Reilley, Matthew, Martin, Linda W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569901/ https://www.ncbi.nlm.nih.gov/pubmed/37667428 http://dx.doi.org/10.1111/1759-7714.15084 |
Ejemplares similares
-
Delayed Healing of Tooth Extraction Sockets with Ramucirumab Use
por: Iijima, Yosuke, et al.
Publicado: (2020) -
Radiation dose mapping and anastomotic complications after trimodality therapy for esophageal cancers
por: Bang, Andrew, et al.
Publicado: (2019) -
Trimodality therapy for esophageal cancer: The role of surgical and radiation treatment parameters in the development of anastomotic complications
por: Alfaifi, Salem, et al.
Publicado: (2021) -
Effective combined therapy with ramucirumab for advanced pulmonary pleomorphic carcinoma
por: Nishioka, Naoya, et al.
Publicado: (2018) -
Ramucirumab-related Oral Pyogenic Granuloma: A Report of Two Cases
por: Aragaki, Tadanobu, et al.
Publicado: (2021)